SMAD6 Antikörper
Kurzübersicht für SMAD6 Antikörper (ABIN969405)
Target
Alle SMAD6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Verwendungszweck
- SMAD6 Antibody
- 
                                            Aufreinigung
- Ascitic fluid
- 
                                            Immunogen
- Purified recombinant fragment of human SMAD6 expressed in E. Coli.
- 
                                            Isotyp
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- ELISA: 1/10000
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- 4 °C,-20 °C
- 
                                            Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
 
- 
                                            
- 
    - 
                                            : "A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension."    in: Journal of medical genetics, Vol. 46, Issue 5, pp. 331-7, (2009)         (PubMed).        
 : "Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation." in: The Journal of biological chemistry, Vol. 281, Issue 6, pp. 3569-76, (2006) (PubMed).
 : "Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1." in: Nature immunology, Vol. 7, Issue 10, pp. 1057-65, (2006) (PubMed).
 
 
- 
                                            : "A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension."    in: Journal of medical genetics, Vol. 46, Issue 5, pp. 331-7, (2009)         (PubMed).        
- 
    - SMAD6 (SMAD, Mothers Against DPP Homolog 6 (SMAD6))
- 
                                            Andere Bezeichnung
- SMAD6
- 
                                            Hintergrund
- Antagonist of signaling by TGF-beta (transforming growth factor) type 1 receptor superfamily members, has been shown to inhibit selectively BMP (bone morphogenetic proteins) signaling by competing with the co-SMAD SMAD4 for receptor-activated SMAD1. SMAD6 is an inhibitory SMAD (I-SMAD) or antagonistic SMAD. Binds to regulatory elements in target promoter regions.Tissue specificity: Ubiquitous in various organs, with higher levels in lung. Isoform B is up-regulated in diseased heart tissue.
- 
                                            Molekulargewicht
- 53 kDa
- 
                                            UniProt
- O43541
- 
                                            Pathways
- Chromatin Binding
 Target
- 
                    
 
                                     
                                     
                                    